Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation
- PMID: 3098684
- PMCID: PMC260297
- DOI: 10.1128/iai.55.1.174-180.1987
Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation
Abstract
The effect of meningococcal cell-associated sialic acid on activation of the human alternative complement pathway was examined by using a quantitative fluorescence immunoassay to assess alternative pathway-mediated C3 binding to a group B strain of Neisseria meningitidis from which graded amounts of sialic acid had been removed with neuraminidase. Using human serum absorbed with strain B16B6 (B:2a:L2,3) and chelated with 10 mM MgCl2 and 10 mM ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid, we found an increase in the amount of C3 bound by enzymatically desialylated B16B6 organisms over the amount bound by fully sialylated organisms. This increase was proportional to the amount of sialic acid cleaved from the bacteria. Enhanced C3 binding was accompanied by an increase in factor B deposition. A sialic acid-deficient mutant of strain B16B6, designated 2T4-1, bound C3 via the alternative pathway at a level equivalent to that bound by wild-type meningococci from which 88% of the sialic acid had been removed. Strain B16B6 was resistant to the alternative pathway-mediated bactericidal activity of both absorbed and hypogammaglobulinemic human sera, whereas noncapsular variant 2T4-1 was sensitive to these sera. The addition of purified immune immunoglobulin M (IgM) and IgG significantly increased the alternative pathway-mediated killing of strain B16B6 organisms. IgM mediated increased bactericidal activity without an increase in C3 or factor B deposition. In contrast, the IgG-mediated killing was associated with increased binding of C3 and factor B to the organisms. Absorption studies showed that the IgM bound to the sialic acid capsule, whereas the IgG bound to noncapsular surface antigens. We conclude from these results that the group B meningococcal sialic acid capsule inhibits activation of the alternative pathway in the nonimmune host and that both IgM and IgG, although specific for different surface antigens, are capable of augmenting the alternative pathway-mediated killing of group B meningococci.
Similar articles
-
Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.Infect Immun. 1997 Oct;65(10):4022-9. doi: 10.1128/iai.65.10.4022-4029.1997. Infect Immun. 1997. PMID: 9317002 Free PMC article.
-
Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule.J Immunol. 1991 Sep 15;147(6):1962-7. J Immunol. 1991. PMID: 1909736
-
Human IgA1 initiates complement-mediated killing of Neisseria meningitidis.J Immunol. 1989 Sep 1;143(5):1703-9. J Immunol. 1989. PMID: 2474610
-
Role of humoral factors in host resistance to the Bacteroides fragilis group.Rev Infect Dis. 1990 Jan-Feb;12 Suppl 2:S161-8. Rev Infect Dis. 1990. PMID: 2406868 Review.
-
Meningococcal disease and the complement system.Virulence. 2014 Jan 1;5(1):98-126. doi: 10.4161/viru.26515. Epub 2013 Oct 8. Virulence. 2014. PMID: 24104403 Free PMC article. Review.
Cited by
-
Infectious diseases associated with complement deficiencies.Clin Microbiol Rev. 1991 Jul;4(3):359-95. doi: 10.1128/CMR.4.3.359. Clin Microbiol Rev. 1991. PMID: 1889047 Free PMC article. Review.
-
Infections of people with complement deficiencies and patients who have undergone splenectomy.Clin Microbiol Rev. 2010 Oct;23(4):740-80. doi: 10.1128/CMR.00048-09. Clin Microbiol Rev. 2010. PMID: 20930072 Free PMC article. Review.
-
The Neisseria meningitidis capsule is important for intracellular survival in human cells.Infect Immun. 2007 Jul;75(7):3594-603. doi: 10.1128/IAI.01945-06. Epub 2007 Apr 30. Infect Immun. 2007. PMID: 17470547 Free PMC article.
-
Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.Infect Immun. 2005 Aug;73(8):4694-703. doi: 10.1128/IAI.73.8.4694-4703.2005. Infect Immun. 2005. PMID: 16040982 Free PMC article.
-
Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.Infect Immun. 1997 Oct;65(10):4022-9. doi: 10.1128/iai.65.10.4022-4029.1997. Infect Immun. 1997. PMID: 9317002 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous